Alternatives to Semaglutide
What are the alternatives to semaglutide? Compare tirzepatide, liraglutide, and other options. Switching protocols, non-medication alternatives, and decision guide.
Tirzepatide avg. loss
~22.5% body weight
Liraglutide avg. loss
~8% body weight
Contrave avg. loss
~5-6% body weight
Bariatric surgery
~25-35% body weight
Pipeline drugs
3+ in Phase 3
Tirzepatide (Mounjaro / Zepbound)
Tirzepatide is the closest alternative to semaglutide and may produce greater weight loss in many patients. As a dual GLP-1/GIP receptor agonist, it activates two incretin pathways compared to semaglutide's one. The SURMOUNT-1 trial showed 22.5% average weight loss at the highest dose vs. semaglutide's 15% in comparable trials.
Considerations for switching: tirzepatide has similar GI side effects but a different titration schedule (2.5mg to 15mg in 2.5mg increments). Some patients who plateau on semaglutide see renewed weight loss after switching. Insurance coverage and compounding availability may differ. Discuss with your provider whether a switch makes sense based on your response and goals.
Liraglutide (Saxenda)
Liraglutide is an older GLP-1 agonist that requires daily injection rather than weekly. It produces less weight loss than semaglutide (approximately 8% vs. 15%), but it remains a viable option for patients who cannot tolerate semaglutide or prefer a more gradual dose escalation. Liraglutide has the longest safety track record of any GLP-1 for weight management, with FDA approval since 2014.
Liraglutide may also be considered for adolescents 12+, as Saxenda has a specific FDA approval for this population. However, for most adult patients, semaglutide or tirzepatide offer superior efficacy.
Other Medication Alternatives
Beyond GLP-1 medications, other FDA-approved weight loss medications include phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and orlistat (Alli/Xenical). These produce less weight loss than GLP-1 agonists (typically 5-10%) but may be appropriate for patients who cannot use GLP-1 medications or as combination therapy.
Emerging options include orforglipron (oral GLP-1 in Phase 3 trials), retatrutide (triple agonist GLP-1/GIP/glucagon), and survodutide (dual GLP-1/glucagon). These pipeline medications may offer new alternatives in the coming years.
Switching Between GLP-1 Medications
If your provider recommends switching from semaglutide to another GLP-1, the typical protocol involves stopping semaglutide and starting the new medication after a washout period of 1-2 weeks. When switching between weekly GLP-1s, some providers start the new medication on the day the next semaglutide dose would have been due.
Dose equivalency is not straightforward between different GLP-1 medications. Your provider will likely start you at a low dose of the new medication and titrate up, even if you were on a high semaglutide dose. This reduces the risk of severe GI side effects from the switch.
Non-Medication Approaches
For patients who cannot or choose not to use GLP-1 medications, evidence-based alternatives include structured behavioral programs (producing 5-10% weight loss), very low-calorie diets under medical supervision, bariatric surgery (for qualifying patients, producing 25-35% weight loss), and comprehensive lifestyle medicine programs combining nutrition, exercise, sleep optimization, and stress management.
Many providers recommend combining semaglutide with lifestyle modifications for optimal results. If cost is the primary barrier, some of these approaches may be more accessible while compounding costs continue to decrease.
Frequently Asked Questions
Is tirzepatide better than semaglutide?
Tirzepatide has shown greater average weight loss in clinical trials (22.5% vs. 15%). However, 'better' depends on individual response, tolerability, insurance coverage, and availability. Some patients respond better to one than the other.
Can I switch from Ozempic to Mounjaro?
Yes, switching between GLP-1 medications is common. Your provider will determine the appropriate starting dose and timing. Expect to start at a low dose and titrate up, even if you were on a high semaglutide dose.
What's the best weight loss medication in 2026?
Tirzepatide (Zepbound) produces the highest average weight loss among currently approved medications. However, individual response varies, and the best medication depends on your specific health profile, insurance coverage, and tolerance.
Are there any oral GLP-1 pills for weight loss?
Rybelsus (oral semaglutide) is available for diabetes but not specifically approved for weight loss at current doses. Orforglipron, a new oral GLP-1 in Phase 3 trials, may offer an oral option specifically for weight loss in the near future.
Compare all GLP-1 medication options and providers
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Semaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.